Advertisement

Pediatric Lymphoma Patients: Cytomegalovirus Infection

  • Samah A. Loutfy
Chapter
Part of the Pediatric Cancer book series (PECA, volume 4)

Abstract

Cancer care has improved and intensified over recent decades, and as patients with cancer survive longer, various infectious complications have been more pronounced. Pediatric cancer patients are at high risk of infectious complications because they are immunologically immature. Human cytomegalovirus (HCMV) is a persistent pathogen, can cause life threatening infection in immunocompromised patients, such as bone marrow and organ transplant recipients, ­persons with AIDS, and patients with hematological malignancies (leukemias and ­lymphomas). Despite Previous studies before application of sensitive molecular methods, demonstrated association of CMV with fever and hepatitis in children with malignancy, CMV has not been extensively studied in pediatric cancer patients. Very limited data are available in the literatures related to symptomatic CMV infection and its clinical relevance on outcome of diseases in pediatric cancer patients especially children with hematological malignancies. These studies are relevant as new advanced diagnostic techniques are now available for detection of the virus in different clinical specimens, ­new advances in the management of CMV infection and disease have been developed, and the performance of prospective clinical trails of antiviral agents has been evaluated. Therefore, the aim of this review is to shade a light on some of these data that are available in the literatures, and relevance of future studies concerned activity of CMV in pediatric lymphoma patients.

Keywords

Hematological Malignancy Lymphoma Patient Pediatric Cancer Patient High Apache Antigenemia Assay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Baldanti F, Simoncini L, Sarasini A, Zavattoni M, Grossi P, Revello MG, Gerna G (1998) Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. Transplantation 66:324–329PubMedCrossRefGoogle Scholar
  2. Bauer CC, Jaksch P, Aberle SW, Haber H, Lang G, Klepetko W, Hofmann H, Puchhammer-Stöckl E (2007) Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol 45:324–328PubMedCrossRefGoogle Scholar
  3. Chemaly RF, Torres HA, Hachem RY, Nogueras GM, Aguilera EA, Younis A, Lina MA, Rodriguez G, Tarrand JJ, Raad II (2005) Cytomegalovirus pneumonia in patients with lymphoma. Cancer 104:1213–1220PubMedCrossRefGoogle Scholar
  4. Church J, Goyals S, Tyagi AK, Scott RAH, Stavrou P (2007) Cytomegalovirus retinitis in chronic lymphocytic leukemia. Eye 21:1230–1233PubMedCrossRefGoogle Scholar
  5. Cvetković RS, Wellington K (2005) Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs 65:859–878PubMedCrossRefGoogle Scholar
  6. Drew WL (1992) Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 14:608–615PubMedCrossRefGoogle Scholar
  7. Drew WL (2000) Ganciclovir resistance: a matter of time and titre. Lancet 356:609–610PubMedCrossRefGoogle Scholar
  8. Ducancelle A, Belloc S, Alain S, Scieux C, Malphettes M, Petit F, Brouet JC, Marie-Le Pors MJC, Mazeron MC (2004) Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy. J Clin Virol 29:241–247PubMedCrossRefGoogle Scholar
  9. Erice A, Chou S, Biron K, Stanat SC, Balfour HH, Jordan JC (1989) Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med 320:289–293PubMedCrossRefGoogle Scholar
  10. Faderl S, Thomas DA, O’Brien S, Garcia-Manero G, Kantarjian HM, Giles FJ, Koller C, Ferrajoli A, Verstovsek S, Pro B, Andreeff M, Beran M, Cortes J, Wierda W, Tran N, Keating MJ (2003) Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies. Blood 101:3413–3415PubMedCrossRefGoogle Scholar
  11. Grigoleit GU, Kapp M, Hebart H, Fick K, Beck R, Jahn G, Einsele H (2007) Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor. J Infect Dis 196:699–704PubMedCrossRefGoogle Scholar
  12. Han XY (2007) Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer. J Clin Microbiol 45:1126–1132PubMedCrossRefGoogle Scholar
  13. Ikewaki J, Ohtsuka E, Kawano R, Ogata M, Kikuchi H, Nasu M (2003) Real-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients. J Clin Microbiol 41:4382–4387PubMedCrossRefGoogle Scholar
  14. Jain M, Duggal S, Chugh TD (2011) Cytomegalovirus infection in non-immunosuppressed critically ill patients. J Infect Dev Ctries 5:571–579PubMedGoogle Scholar
  15. Jones GR, Konsler GK, Dunaway RP, Pusek SN (1996) Infection risk factors in febrile, neutropenic children and adolescents. J Pediatr Hematol Oncol 13:217–229CrossRefGoogle Scholar
  16. Koh AY, Pizzo PA (2011) Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p 1190Google Scholar
  17. Ljungman P, Griffiths P, Paya C (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34:1094–1097PubMedCrossRefGoogle Scholar
  18. Ljungman P, de la Camara R, Cordonnier C, Einsele H, Engelhard D, Reusser P, Styczynski J, Ward K (2008) Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 42:227–240PubMedCrossRefGoogle Scholar
  19. Loutfy SA, Mansout MT (2000) Cytomegalovirus infection in immunocompromised cancer patients: immunovirological study. PhD thesis, National Cancer Institute, Cairo University, EgyptGoogle Scholar
  20. Loutfy SA, Ibrahim MF, El-Wakil M, Moneer MM (2010) Presence of Human Herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection. Virol J 7:287PubMedCrossRefGoogle Scholar
  21. Madi N, Al-Nakib W, Mustafa AS, Saeed T, Pacsa A, Nampoory MR (2007) Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR. Med Princ Pract 16:268–273PubMedCrossRefGoogle Scholar
  22. Meyers JD, Ljungman P, Fisher LD (1990) Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis 162:373–380PubMedCrossRefGoogle Scholar
  23. Nguyen Q, Estey E, Raad I, Rolston K, Kantarjian H, Jacobson K, Konoplev S, Ghosh S, Luna M, Tarrand J, Whimbey E (2001) Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis 32:539–545PubMedCrossRefGoogle Scholar
  24. Razonable RR, Paya CV, Smith TF (2002) Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol 40:746–752PubMedCrossRefGoogle Scholar
  25. Reusser P (2002) Management of viral infections in immunocompromised cancer patients. Swiss Med Wkly 132:374–378PubMedGoogle Scholar
  26. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ (2006) Seroprevalence of cytomegalovirus infection in the United States 1988-1994. Clin Infect Dis 43:1143–1151PubMedCrossRefGoogle Scholar
  27. Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87(Pt 7):1763–1779PubMedCrossRefGoogle Scholar
  28. Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF (2006) Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma 6:393–398PubMedCrossRefGoogle Scholar
  29. Torres HA, Aguilera E, Safdar A, Rohatgi N, Raad II, Sepulveda C, Luna M, Kontoyiannis DP, Chemaly RF (2008) Fatal cytomegalovirus pneumonia in patients with hematological malignancies: an autopsy-based case-control study. Clin Microbiol Infect 14:1160–1166PubMedCrossRefGoogle Scholar
  30. Vancíková Z, Dvorák PC (2001) Cytomegalovirus infection in immunocompetent and immunocompromised individuals – a review. Curr Drug Immune Endocr Metabol Disord 1:179–187CrossRefGoogle Scholar
  31. Wade JC (2006) Viral infections in patients with hematological malignancies. Hematology Am Soc Hematol Educ Program: 368–374Google Scholar
  32. Wang F, Yao K, Yin QZ, Zhou F, Ding CL, Peng GY, Xu J, Chen Y, Feng DJ, Ma CL, Xu WR (2006) Human herpesvirus-6 specific interleukin 10-producing CD4+ T cells suppress the CD4+ T-cell response in infected individual. Microbiol Immunol 50:787–803PubMedGoogle Scholar
  33. Wang YC, Wang NC, Lin JC, Perng CL, Yeh KM, Yang YS, Chiu CH, Chang FY (2011) Risk factors and outcomes of cytomegalovirus viremia in cancer patients: a study from a medical center in northern Taiwan. J Microbiol Immunol Infect 44:442–448PubMedCrossRefGoogle Scholar
  34. Yee-Guardino S, Gowans K, Yen-Lieberman B, Berk P, Kohn D, Wang FZ, Danziger-Isakov L, Sabella C, Worley S, Pellett PE, Goldfarb J (2008) Beta-herpesviruses in febrile children with cancer. Emerg Infect Dis 14:579–585PubMedCrossRefGoogle Scholar
  35. Yeung SCJ, Escalante CP, Gagel RF (2009) Pneumonia in cancer patients. In Medical Care of Cancer Patients. Sai-Ching Jim Y, Carmen PE, Robert FG. 1st ed, BC Decker Inc. Texas, pp 331. patients. J Clin Microbiol 30:527–530Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.Virology and Immunology, Cancer Biology Department, National Cancer InstituteCairo UniversityGizaEgypt

Personalised recommendations